MedTrace Logo

Atropine in Laparoscopic Gynaecological Surgery

NCT02769325 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2016-05-11

No results posted yet for this study

Summary

This is a double blinded, randomised controlled trial that will compare atropine to placebo for postoperative pain in laparoscopic gynaecological surgery

Conditions

  • Laparoscopic Surgery
  • Gynecology

Interventions

DRUG

Atropine

IV atropine 0.1%, 10 ml

DRUG

Placebo

IV saline, 10 ml

DRUG

Sevoflurane

All patients will receive anaesthesia based on sevoflurane, titrated to a bis of 45-60

DRUG

sugammadex

Patients will receive sugamadex for neuromuscular reversion, if necessary

DRUG

Ketorolac

60 mg IV ketorolac will be administered at induction, and patients will receive 30mg/8h on the postoperative period

DRUG

Morphine PCA

Patients will receive a PCA of morphine with a program of 0 (continuous infusion), 1 mg bolus and 8 minutes lockout

DRUG

rocuronium

general anaesthesia will use rocuronium 0.6 mg/kg to facilitate intubation

DRUG

propofol

for anaesthesia induction, patients will receive 2-3 mg/kg iv propofol

Sponsors & Collaborators

  • Clinica Santa Maria

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-05-31
Completion
2017-08-31

Countries

  • Chile

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02769325 on ClinicalTrials.gov